Full Text

Turn on search term navigation

© 2024 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. BMJ http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Correspondence to: K Ruggeri [email protected] Key messages Substantial evidence shows the negative effects of vaccine misinformation on social media Evidence on the effectiveness of interventions to correct or mitigate misinformation is considerably more limited and rarely includes measures of true vaccine uptake The evidence available does indicate ways forward to develop better methods, particularly those that would be less likely to backfire in the way that blanket social media bans have The need for such actions is urgent Vaccine misinformation on social media has strong effects on behaviour, and the evidence base for interventions to reduce these effects is limited, but better approaches to evidence generation are possible, say Kai Ruggeri and colleagues Effective population level vaccination campaigns are fundamental to public health.123 Counter campaigns, which are as old as the first vaccines,4 disrupt uptake and can threaten public health globally.4 In 2019, public health researchers linked increases in measles cases with the proliferation of global anti-vaccine campaigns.5 Some of these campaigns originated offline but were later amplified and expedited through social media, resulting in real world harms.6 Though crises and genuine safety concerns can also lower vaccine uptake,78 the return of measles after aggressive anti-vaccine campaigns prompted the World Health Organisation to list vaccine hesitancy among the greatest threats to global health (box 1).14 Box 1 Vaccine hesitancy Here, we use the term “vaccine hesitancy” as originally defined by WHO9: a “delay in acceptance or refusal of vaccination despite availability of vaccination services.” Anti-vaccine campaigns proliferated during the covid-19 pandemic15 with undeniable effects including substantial increases in covid related illness and death.151617 Even before March 2020, vaccine hesitancy was directly linked to misinformation (false, inaccurate information promoted as factual) spread on social media.18 Once covid-19 reached pandemic status, social media was acknowledged as the epicentre of misinformation leading to hesitancy,1920 and consequently, interventions to tackle hesitancy have globally focused on delivery through social media.2122 Despite unprecedented levels of vaccine access and nearly real time communication on the development and availability of vaccines in 2020-21, public health officials struggled to keep pace with misleading or inaccurate content online.23 As guidelines shifted with the emergence of new information, policy decisions were often perceived by individuals and groups who are prone to distrust or refute government messaging as a response not to evidence but to mistakes or lack of expertise.2425 A 2021 randomised controlled trial (RCT) found that exposure to misinformation about covid-19 vaccines lowered the intent of recipients to vaccinate, even among those reporting before exposure that they would “definitely” accept vaccination.21 Similar findings globally indicate that social media dynamics exacerbated the sharing of misinformation, reduced vaccination rates, undermined trust in reliable information, magnified polarisation, and damaged the perceived credibility of institutions.2627282930 These challenges remain today. Approaches to reducing vaccine hesitancy Standard behavioural approaches to encourage vaccination include mandatory vaccination and regulation for healthcare professionals, incentives, public health communication campaigns, and engaging trusted leaders.31 Contemporary methods have started to be implemented on social media,10313233 including debunking (fact checking specific claims after they have reached social media users) and “pre-bunking,” a behavioural approach in which users are taught about how “fake news” works before exposure.34 Other intervention types include warning (“inoculating”) people about manipulation tactics using non-harmful exposure as a tool to identify misinformation, and using accuracy prompts to trigger people to consider the truthfulness of material they are about to share on social media platforms, without stopping them from posting.35 Recognising the intense effect of social media on vaccine hesitancy,36 the Africa Centres for Disease Control and Prevention developed a toolkit to assist countries in social media strategies aimed at encouraging vaccination.37 Such behavioural approaches to misinformation on social media have shown promise in reducing the sharing of disinformation and misinformation (box 1) and in changing people’s beliefs,38 but less clear is their effect on vaccination uptake. Investigating the success of such interventions on uptake is essential because there is an established link between social media exposure and offline beliefs that vaccines are unsafe.39 It is clear, however, that providing fact based probabilistic information alone fails to meaningfully increase uptake40 and might even backfire.41 Factors such as low trust in governments and health institutions are likely to be instrumental in derailing effective immunisation programmmes.42 Multiple drivers and barriers to vaccine uptake must therefore be considered when developing effective tools.

Details

Title
Behavioural interventions to reduce vaccine hesitancy driven by misinformation on social media
Author
Ruggeri, Kai; Vanderslott, Samantha; Yamada, Yuki; Young Anna Argyris; Većkalov, Bojana; Boggio, Paulo Sergio; Fallah, Mosoka P; Stock, Friederike; Hertwig, Ralph
First page
e076542
Section
Analysis
Publication year
2024
Publication date
Jan 16, 2024
Publisher
BMJ Publishing Group LTD
e-ISSN
17561833
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2915038545
Copyright
© 2024 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. BMJ http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.